Publications

Publications of the Eichmüller group (since 2010)

Requesting PDFs

All reprints are available as PDF for personal use on request

Most recent publications

Asterisks delineate equal contribution.

2019

  • Backhaus PS, Veinalde R, Hartmann L, Dunder JE, Jeworowski LM, Albert J, Hoyler B, Poth T, Jager D, Ungerechts G, and Engeland CE (2019) Immunological Effects and Viral Gene Expression Determine the Efficacy of Oncolytic Measles Vaccines Encoding IL-12 or IL-15 Agonists. Viruses 11
  • Katsanovskaja K, Driver T, Pipkorn R, and Edelson-Averbukh M (2019) Negative Ion Mode Collision-Induced Dissociation for Analysis of Protein Arginine Methylation. J Am Soc Mass Spectrom 30: 1229-1241.
  • Das K, Eisel D, Vormehr M, Müller-Decker K, Hommertgen A, Jäger D, Zörnig I, Feuerer M, Kopp-Schneider A, Osen W, and Eichmüller SB (2019) A transplantable tumor model allowing investigation of NY-BR-1-specific T cell responses in HLA-DRB1*0401 transgenic mice. BMC Cancer 19:914. Link to full text
  • Gangkofner DS, Holzinger D, Schröder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic J, Marienfeld RB, Möller P, Völkel G, Kraus J, Kestler H, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Döscher J, Hoffmann TK, Pawlita M, Waterboer T, and Laban S (2019) Patterns of antibody responses to non-viral cancer antigens in head and neck squamous cell carcinoma patients differ by Human papillomavirus status. Int J Cancer 145, 3436-3444.
  • Laban S, Gangkofner DS, Holzinger D, Schroeder L, Eichmüller SB, Zörnig I, Jäger D, Wichmann G, Dietz A, Broglie MA, Herold-Mende C, Dyckhoff G, Boscolo-Rizzo P, Ezic RB, Marienfeld RB, Möller P, Völkel G, Kraus J, Kestler H, Brunner C, Schuler PJ, Wigand M, Theodoraki MN, Döscher J, Hoffmann TK, Pawlita M, Waterboer T, and Butt J (accepted) Antibody responses to cancer antigens identify patients with a poor prognosis among HPV-positive and HPV-negative head and neck squamous cell carcinoma patients. Clin Cancer Res
  • Eisel D, Das K, Dickes E, König R, Osen W, and Eichmüller SB (2019) Cognate interaction with CD4+ T cells instructs tumor-associated macrophages to acquire M1-like phenotype. Front Immunol 10(219). Link to full text
  • Sharbi-Yunger A, Grees M, Gal C, Bassan D, Eichmüller SB, Tzehoval E, Utikal J, Umansky V, and Eisenbach L (2019) A universal anti-cancer vaccine: chimeric invariant chain potentiates the inhibition of melanoma progression and improvement of survival. Int J Cancer 144: 909-921.

2018

  • Ast V*, Kordaß T*, Oswald M, Kolte A, Eisel D, Osen W, Eichmüller SB, Berndt A, and König R (2018) MiR-192, miR-200c and miR-17 are fibroblast-mediated inhibitors of colorectal cancer invasion. Oncotarget 9: 35559-35580. Link to full text
  • Kordaß T, Weber CEM, Eisel D, Pane AA, Osen W, and Eichmüller SB (2018) miR‑193b and miR-30c-1* inhibit, whereas miR-576-5p enhances melanoma cell invasion. Oncotarget 9(65): 32507-32522. Link to full text
  • Kordaß T, Osen W, and Eichmüller SB (2018) Controlling the immune suppressor: transcription factors and miRNAs regulating CD73/NT5E. Frontiers in Immunology, 9(813). Review. Link to full text
  • Grees M et al. (2018) Optimized dendritic cell vaccination induces potent CD8 T cell responses and anti-tumor effects in transgenic mouse melanoma models. Oncoimmunology 7(7): e1445457. Link to full text
  • Michels J et al. (2018) Multiplex bead-based measurement of humoral immune responses against tumor-associated antigens in stage II melanoma patients of the EORTC 18961 trial. Oncoimmunology 7: e1428157. Link to full text
  • Krackhardt AM et al. (2018) Clinical translation and regulatory aspects of CAR/TCR-based adoptive cell therapies - the German Cancer Consortium approach. Cancer Immunol Immun 67(4):513-523. (request reprint)
  • Lv N et al. (2018) miR-137 inhibits melanoma cell proliferation through downregulation of GLO1. Sci China Life Sci 61: 541-549. Link to full text or request reprint

2017

  • Das K*, Eisel D*, et al. (2017) Generation of murine β2-microglobulin deficient tumor cell lines using the CRISPR/Cas9 system. PLoS ONE 12: e0174077. Link to full text
  • Eichmüller SB, Osen W, Mandelboim O, and Seliger B (2017) Immune modulatory microRNAs involved in tumor attack and tumor immune escape. J Natl Cancer Inst. Link to full text

 

2016

  • Weber CEM et al. (2016) miR-339-3p is a tumor suppressor in melanoma. Cancer Res 76: 3562-3571. Link to full text.
  • Werner S et al. (2016) Evaluation of the diagnostic value of 64 simultaneously measured autoantibodies for early detection of gastric cancer. Scientific Reports 6: 25467. Link to full text.
  • Kordaß T et al. (2016) SOX5 is involved in balanced MITF regulation in human melanoma cells. BMC Med Genomics 9: 10. Link to full text.
  • Chen H et al. (2016) Prospective evaluation of 64 serum autoantibodies as biomarkers for early detection of colorectal cancer in a true screening setting. Oncotarget 7: 16420-32. Link to full text.

2015

  • Gardyan A*, Osen W* et al. (2015) Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice. Int J Cancer 136: 2588-97.
  • Zörnig I et al. (2015) Prognostic significance of spontaneous antibody responses against tumor-associated antigens in malignant melanoma patients. Int J Cancer 136: 138-51.
  • Pfirschke C et al. (2015) T cell responses in early-stage melanoma patients occur frequently and are not associated with humoral response. Cancer Immunol Immunother 64: 1369-81.
  • Lei J et al. (2015) Replication-Competent Foamy Virus Vaccine Vectors as Novel Epitope Scaffolds for Immunotherapy. Plos One 10: e0138458.
  • Hao S et al. (2015) miR-137 inhibits proliferation of melanoma cells by targeting PAK2. Exp Dermatol 24: 947-52.
  • Amann PM et al. (2015) LRAT overexpression diminishes intracellular levels of biologically active retinoids and reduces retinoid anti-tumor efficacy in the murine melanoma B16F10 cell line. Skin Pharmacol Physiol 28: 205-12.

2014

  • Schumacher T et al. (2014) A vaccine targeting mutant IDH1 induces antitumor immunity. Nature 512: 324-7.
  • Schacht T et al. (2014) Estimating the activity of transcription factors by the effect on their target genes. Bioinformatics 30: i401-i7.
  • Luo C et al. (2014) The role of microRNAs in melanoma. Eur J Cell Biol 93: 11-22.
  • Amann PM et al. (2014) Knockdown of lecithin retinol acyltransferase increases all-trans retinoic acid levels and restores retinoid sensitivity in malignant melanoma cells. Exp Dermatol 23: 832-7.

2013

  • Simon-Keller K et al. (2013) Survivin blockade sensitizes rhabdomyosarcoma cells for lysis by fetal acetylcholin receptor-redirected T cells. Am J Pathol 182: 2121-31.
  • Luo C et al. (2013) miR-137 inhibits the invasion of melanoma cells through downregulation of multiple oncogenic target genes. J Invest Dermatol 133: 768-75.
  • Luo C et al. (2013) MiR-101 inhibits melanoma cell invasion and proliferation by targeting MITF and EZH2. Cancer Letters 341: 240-7.
  • Hassel JC et al. (2013) Lecithin/retinol acyltransferase as a potential prognostic marker for malignant melanoma. Exp Dermatol 22: 757-9.

2012

  • Savchenko MS et al. (2012) Autoantibodies against a Ca2+-binding protein recoverin in blood sera of patients with various oncological diseases. Oncology Letters 3: 377-82.
  • Grund SE et al. (2012) Rare Drosha splice variants are deficient in microRNA processing but do not affect general microRNA expression in cancer cells. Neoplasia 14: 238-48.
  • Bai AH et al. (2012) MicroRNA-182 promotes leptomeningeal spread of non-sonic hedgehog-medulloblastoma. Acta Neuropathol 123: 529-38.
  • Amann PM et al. (2012) Vitamin A metabolism in benign and malignant skin cells: Importance of lecithin/retinol acyltransferase and RPE65. J Cell Physiol 227: 718-28.
  • Amann PM et al. (2012) Expression and activity of alcohol and aldehyde dehydrogenases in melanoma cells and in melanocytes. J Cell Biochem 113: 792-9.
  • Abschuetz O*, Osen W* et al. (2012) T-cell mediated immune responses induced in ret transgenic mouse model of malignant melanoma. Cancers 4: 490-503.

Before 2012

See complete list of all publications by Stefan Eichmüller (PDF file).

to top